Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Pharmacokinetic–Pharmacodynamic Relationship: Problems01:24

Pharmacokinetic–Pharmacodynamic Relationship: Problems

The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of deep learning architectures for predicting ligand interactions with neurologically relevant GPCRs.

Journal of cheminformatics·2026
Same author

ToxMet: a web tool for toxicogenomic data analysis using genome-scale metabolic modeling.

Toxicological sciences : an official journal of the Society of Toxicology·2026
Same author

Post-Deployment Screening of Thailand Military Units Deployed to South Sudan from 2023 to 2025 Reveals High Rates of Sub-Microscopic <i>P. falciparum</i> Malaria.

Tropical medicine and infectious disease·2026
Same author

Modeling hERG Channel Liability: From Structural Insight to Highly Accurate Qualitative and Quantitative Models.

Journal of chemical information and modeling·2026
Same author

Evaluating the Usability, Durability, and Effectiveness of Permethrin-Treated Uniforms and Metofluthrin Spatial Repellent in Preventing Mosquito Bites in the Laos Military.

Tropical medicine and infectious disease·2026
Same author

Cross-bridge model-based quantification of muscle metabolite alterations leading to fatigue during all-out knee extension exercise.

Frontiers in physiology·2026

Related Experiment Video

Updated: May 26, 2026

A Semi-Quantitative Drug Affinity Responsive Target Stability (DARTS) assay for studying Rapamycin/mTOR interaction
05:28

A Semi-Quantitative Drug Affinity Responsive Target Stability (DARTS) assay for studying Rapamycin/mTOR interaction

Published on: August 27, 2019

Exploring polypharmacology using a ROCS-based target fishing approach.

Mohamed Diwan M AbdulHameed1, Sidhartha Chaudhury, Narender Singh

  • 1Biotechnology High Performance Computing Software Applications Institute, Telemedicine and Advanced Technology Research Center, U.S. Army Medical Research and Materiel Command, Fort Detrick, Maryland 21702, USA. mabdulhameed@bioanalysis.org

Journal of Chemical Information and Modeling
|December 27, 2011
PubMed
Summary

This study introduces a ligand-based target fishing (LBTF) protocol to explore polypharmacology in drug discovery. The method effectively predicts drug targets and off-targets, showing promise for drug repurposing and safety assessments.

Related Experiment Videos

Last Updated: May 26, 2026

A Semi-Quantitative Drug Affinity Responsive Target Stability (DARTS) assay for studying Rapamycin/mTOR interaction
05:28

A Semi-Quantitative Drug Affinity Responsive Target Stability (DARTS) assay for studying Rapamycin/mTOR interaction

Published on: August 27, 2019

Area of Science:

  • Computational chemistry
  • Pharmacology
  • Drug discovery

Background:

  • Polypharmacology, the ability of a drug to interact with multiple targets, is a key theme in modern drug discovery.
  • Understanding these interactions is crucial for developing effective and safe therapeutics.

Purpose of the Study:

  • To develop and validate a ligand-based target fishing (LBTF) protocol for studying polypharmacology.
  • To assess the potential of this protocol for drug repurposing, target identification, and adverse effect prediction.

Main Methods:

  • Generated a chemogenomic database linking protein targets with representative drugs.
  • Computed molecular shape and chemistry overlap using ROCS (Rapid Overlay of Chemical Structures) to generate target profiles.
  • Validated the LBTF protocol using the Directory of Useful Decoys (DUD) dataset and analyzed Receiver Operator Characteristic (ROC) curves and Area Under the Curve (AUC) values.

Main Results:

  • The LBTF protocol demonstrated significantly better performance than random selection for most targets studied.
  • The method successfully identified known off-targets for drugs like rimantadine, propranolol, and domperidone, consistent with experimental findings.
  • AUC values indicated the efficacy of the ROCS-based approach in virtual screening.

Conclusions:

  • The developed ROCS-based LBTF protocol is a promising tool for polypharmacology research.
  • This approach has significant potential applications in drug repurposing, identifying targets for orphan compounds, and predicting adverse drug effects.